Navigation Links
United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStem's Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
Date:10/7/2009

statements include the "Risk Factors" described in the Company's Registration Statement on Form S-4/A filed with the Commission on October 6, 2009 as well as periodic filings made with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

Additional Information about the Merger and Where to Find It

NeoStem recently filed a Proxy Statement/Registration Statement with the SEC with respect to the shares of NeoStem Common Stock to be issued in connection with the Merger. Investors and security holders are advised to read the Proxy Statement/Registration Statement because it contains important information about NeoStem, China Biopharmaceuticals (CBH), the proposed Merger and other related matters. The final Proxy Statement/Registration Statement will be sent to stockholders of NeoStem seeking their approval of the proposed transaction. Investors and security holders will be able to obtain the documents free of charge at the SEC's web site, http://www.sec.gov. Since such final documents are not currently available, NeoStem's stockholders will receive information at an appropriate time as to how to obtain transaction-related documents free of charge from NeoStem.

This press release may be deemed to be solicitation material in respect of the proposed Merger. The directors and executive officers of each of NeoStem and CBH may be deemed to be participants in the solicitation of proxies from the holders of NeoStem Common Stock in respect of the proposed transaction. Information about the directors and executive officers of NeoStem is set forth in NeoStem's Proxy Statement for its 2009 Annual Meeting of Stockholders filed with the SEC on April 14, 2009 and in subsequent Forms 8-K. Investors may obtain additional information regarding the interest of N
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
2. Masimo Radical-7(R) and Rad-57(R) Pulse CO-Oximeters(TM) Awarded Airworthiness Release Certification by the United States Army
3. United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend
4. Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States
5. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
6. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
7. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
8. United States FDA Clears the REGEN Trial to Test Biohearts Combination Gene and Stem Cell Therapy in Heart Failure Patients
9. United Therapeutics Corporation to Announce Second Quarter 2009 Financial Results Before Market Open on Friday, July 31, 2009
10. LS9's UltraClean Diesel Exceeds United States & Brazilian Fuels Specifications
11. NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... --  Flexion Therapeutics , Inc. today announced the addition ... its management team as chief financial officer. Mr. Driscoll ... with biotechnology and medical device companies. Prior ... for Novavax (NASDAQ: NVAX ) where he ... through a combination of investment funding and commercial and ...
(Date:5/20/2013)... Recognizing exciting and innovative scientific research, ... 2013 Class of Young Professors. Over the ... outstanding international group with more than $824,000 to ... meet global challenges.     , The DuPont Young Professor ... untenured research faculty working in areas of interest ...
(Date:5/20/2013)... City, CA (PRWEB) May 20, 2013 ... has announced the appointment of Lisa Baird as Executive ... on July 8, 2013. The WMIS vision ... imaging applications to understand and effectively treat diseases in ... Imaging Society (WMIS) was established in 2011 by integrating ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Dr. Sparano ... and Women’s Health at the Albert Einstein College of ... at the Montefiore Medical Center. He is also ... Center and leads the Einstein Breast Cancer Working Group, ... translational breast cancer research. He also serves as Vice ...
Breaking Biology Technology:Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 2DuPont Celebrates Scientific Innovation by Recognizing Young Professors 3WMIS Appoints Lisa Baird as Next Executive Director 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... DALLAS, Aug. 13 Access Pharmaceuticals, Inc.,(OTC Bulletin Board: ... the Fourth Annual Noble Financial Equity Conference to be ... Resort, Nevada. Jeffrey B. Davis,CEO of Access is scheduled ... a.m.,Pacific time (12:00 noon Eastern), and will give a ...
... Additional Testing Services Provided by Interleukin ... ... Aug. 13 ,Interleukin Genetics, Inc. (Amex: ILI ), and OralDNA ... agreement,for Interleukin Genetics, proprietary PST(R) Genetic Test. The PST(R),Genetic Test provides ...
... the benefits of its Bio-Forge® product line through the use of ... an overview of Stoller,s proprietary technology, plant growth cycles and hormone ... them to flourish. , ... Houston, TX (PRWEB) August ...
Cached Biology Technology:Access Pharmaceuticals to Present at the Noble Financial Equity Conference 2Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs 2Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs 3Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs 4StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress 2StollerUSA Launches Bio-Forge.com to Offer Solutions for Crops Under Stress 3
(Date:5/17/2013)... international team of scientists using a new X-ray method ... living frog embryo in greater detail than ever before., ... research and the search for new treatments for genetic ... fr Technologie in Germany, in collaboration with the Advanced ... National Laboratory, released the most precise depiction ever of ...
(Date:5/16/2013)... living closer to a fast food restaurant had a ... further away from fast food, according to researchers at ... this association was particularly strong among those with a ... in the American Journal of Public Health ... fast food restaurant, and among lower-income African-Americans, the density, ...
(Date:5/16/2013)... endothelium, the cellular layer lining the body,s blood ... hundred nanometers in thickness, this super-tenuous structure routinely ... compression to create a unique and highly dynamic ... tissues from the body,s circulatory system. , It,s ... must be physically breached to enable immune ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... A new audit report issued by the International Osteoporosis ... growing problem throughout Asia. Gathering data from 14 ... landmark report examining epidemiology, costs and burden in individual countries ... findings include: A major increase in fractures is ...
... , NEW YORK, Sept. 8 Reportlinker.com ... its catalogue. , , Carbon ... http://www.reportlinker.com/p0131250/Carbon-Dioxide-Monitors.html , , This report analyzes ... US$ by the following segments: End-tidal Carbon Dioxide (EtCO2) Monitors, ...
... , , BEDFORD, Mass., ... a global provider of imaging and biometrics software, today announced ... services to Lockheed Martin,s high-performance fingerprint card scanning service. ... a five-year, $47 million contract to continue managing the FBI ...
Cached Biology News:New report shows rising tide of fractures in Asia 2New report shows rising tide of fractures in Asia 3Reportlinker Adds Carbon Dioxide Monitors Report 2Reportlinker Adds Carbon Dioxide Monitors Report 3Reportlinker Adds Carbon Dioxide Monitors Report 4Reportlinker Adds Carbon Dioxide Monitors Report 5Reportlinker Adds Carbon Dioxide Monitors Report 6Reportlinker Adds Carbon Dioxide Monitors Report 7Reportlinker Adds Carbon Dioxide Monitors Report 8Reportlinker Adds Carbon Dioxide Monitors Report 9Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning 2Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning 3
Black Polypropylene 384 Round Well Plate 70/Box...
... Rabbit polyclonal to Peroxiredoxin 1 ... family, whose mammalian members have been ... differentiation, and apoptosis. Many isoforms (about ... the amino acid sequence homology, particularly ...
... Eliminates nonspecific products due to inactivity ... allows extension through DNA regions which contain ... an 'A' overhang ,TEMPase II is ... Polymerase that remains inactive at room ...
... to beta Synuclein Synucleins are small, ... and in certain tumors. The family includes ... and gamma synuclein. The alpha and beta ... tissue, where they are seen mainly in ...
Biology Products: